Portland, OR, March 31, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Osteoporosis Drugs Market held nearly $7.65 billion in 2018, and is projected to reach $10.47 billion by 2026, growing at a CAGR of 3.9% from 2019 to 2026. The report provides an extensive analysis of changing market trends, market size, trends, & estimations, top investment pockets, key segments, and competitive scenarios.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/1491
Increase in prevalence of osteoporosis, increase in the aging population, and adoption of sedentary lifestyle across the world drive the growth of the global osteoporosis drugs market. However, side effects related to osteoporosis drugs and time-consuming approval processes for drugs hinder the market growth. On the other hand, high potential for growth in developing countries would offer new opportunities in the coming years.
Based on drug class, the bisphosphonates segment held more than one-third of the total market share in 2018, and is estimated to maintain its largest share in terms of revenue throughout the forecast period. However, the rank ligand inhibitors segment is estimated to witness the highest CAGR of 8.6% from 2019 to 2026. The report also analyzes segments including selective estrogen inhibitors modulator (SERM), parathyroid hormone therapy, calcitonin, and others.
Based on route of administration, the oral segment accounted for nearly three-fifths of the total share in 2018, and is estimated to maintain its lead status throughout the forecast period. However, the injectable segment is estimated to portray the largest growth rate with a CAGR of 4.4% from 2019 to 2026.
Based on region, North America held the largest market share in terms of revenue, contributing to nearly half of the total share in 2018, and is estimated to maintain its dominant share during the forecast period. However, LAMEA is estimated to witness the highest CAGR of 5.5% from 2019 to 2026. Asia-Pacific is expected to maintain a CAGR of 4.4% during the forecast period.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1491
Leading market players analyzed in the research include Amgen Inc., Radius Health, Inc., F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, Novartis International AG (Sandoz), Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Pfizer Inc., and Teva Pharmaceutical Industries Ltd. They have adopted various strategies including new product launches, collaborations, partnerships, mergers & acquisitions, and others to gain a strong position and international presence across the world.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Similar Reports:
Thyroid Function Test Market: Opportunity Analysis and Industry Forecast, 2019–2026
Influenza Treatment Market: Global Opportunity Analysis and Industry Forecast, 2019–2026
UV Infection Control Devices Market: Global Opportunity Analysis and Industry Forecast, 2019–2026
Home Medical Equipment Market: Global Opportunity Analysis and Industry Forecast, 2019–2026
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.